The Ankle-Brachial Index (ABI) is a vital indicator for detecting Peripheral Arterial Disease (PAD), a serious cardiovascular condition that can significantly impact your health and quality of life.

Why PAD Matters

PAD is associated with a high mortality rate, making early detection and management crucial for better health outcomes.

The ABI Challenge
Despite its importance, ABI measurements are not routinely performed in many healthcare settings. Why? The traditional method using Doppler ultrasound is:

• Time-consuming
• Complex to administer
• Requires specialised training

The Smartest Wireless Ankle-Brachial Index
MESI mTABLET ABI for Australian Healthcare Professionals

The MESI mTABLET ABI offers Australian GP's and healthcare professionals a game-changing solution for quick and accurate Peripheral Arterial Disease (PAD) detection. This innovative device streamlines the measurement of Ankle-Brachial Index (ABI), a critical indicator of cardiovascular health.

The MESI mTABLET ABI is an innovative medical device designed to revolutionise Peripheral Arterial Disease (PAD) screening in Australian general practices and healthcare settings. This advanced diagnostic tool offers a quick and efficient method for measuring the Ankle-Brachial Index (ABI), a crucial indicator of PAD.

Key Features for Australian GPs:

• Rapid ABI Measurement: Perform the world's fastest ABI test, saving valuable consultation time.
• Wireless and Automated: 3CUFF™ technology allows simultaneous measurement of brachial and ankle pressures.
• Smart Integration: Easily incorporate into existing Electronic Health Record (EHR) systems used in Australian clinics.
• Versatile Applications: Ideal for primary care, vascular medicine, and chronic disease management in the Australian healthcare context.
• Multiple Diagnostic Tools: Expandable platform including ECG, spirometry, and blood pressure measurements.

Benefits for Australian Healthcare

• Early PAD Detection: Crucial for managing cardiovascular risks in the ageing Australian population.
• Time-Efficient: Streamlines the diagnostic process, allowing more patient consultations.
• Improved Patient Outcomes: Enables early intervention and better management of vascular health.
• Cost-Effective: Reduces the need for referrals to specialist vascular clinics.

The MESI mTABLET ABI is an essential tool for Australian GPs and healthcare professionals committed to enhancing cardiovascular
screening and improving patient care in primary healthcare settings.

Key Features and Benefits for Medical Practitioners

• Accurate ABI Measurements: Provides reliable and quick ABI measurements essential for diagnosing PAD. Its advanced sensors ensure high precision, reducing the risk of misdiagnosis and enabling early detection, which allows for timely intervention and improved patient outcomes.
• Wireless Connectivity: Seamlessly integrates with the MESI mTABLET platform for wireless data transfer and storage, enhancing workflow efficiency and enabling easy access to patient records, thus streamlining administrative tasks and allowing healthcare providers to focus more on patient care.
• User-Friendly Design: The intuitive interface and straightforward operation make it accessible for healthcare professionals, ensuring accurate results with minimal training. This ease of use supports enhanced patient care through improved diagnostic services and personalised care plans.
• Comprehensive Reporting: Generates detailed reports that can be easily shared with patients and specialists, facilitating better communication and informed decision-making in treatment planning. This feature improves patient engagement and compliance with treatment plans.
• Portability: Lightweight and portable, the system is ideal for use in various healthcare settings, from clinics to hospitals, ensuring flexibility and convenience in patient care.
• Cost-Effective Solution: By improving diagnostic accuracy and efficiency, the MESI mTABLET ABI system can reduce long-term healthcare costs associated with PAD complications.

Why Upgrade to the MESI mTABLET ABI System?

• Advanced Technology: Represents the latest in diagnostic technology, offering superior accuracy and efficiency compared to traditional methods.
• Future-Proof Your Practice: Ensures your practice remains at the forefront of medical innovation, ready to meet evolving healthcare standards.
• Scalability and Integration: As part of the MESI mTABLET ecosystem, the ABI diagnostic module can be easily expanded with additional diagnostic tools, offering a scalable solution that grows with your practice's needs.

Equip your practice with the MESI mTABLET ABI system and elevate your diagnostic capabilities.
Ensure the best care for your patients with this state-of-the-art tool designed specifically for healthcare professionals in Australia.

Benefits for Australian Healthcare

• Early PAD Detection: Crucial for managing cardiovascular risks in the ageing Australian population.
• Time-Efficient: Streamlines the diagnostic process, allowing more patient consultations.
• Improved Patient Outcomes: Enables early intervention and better management of vascular health.
• Cost-Effective: Reduces the need for referrals to specialist vascular clinics.

The MESI mTABLET ABI is an essential tool for Australian GPs and healthcare professionals committed to enhancing cardiovascular screening and improving patient care in primary healthcare settings.

Contact your Key Account Manager or our Customer Service Team to learn more, request a demonstration, or place an order.

Additional Resources for MESI mTABLE ECG